U.S. Capital Markets Stock News

NasdaqGS:PLMR
NasdaqGS:PLMRInsurance

Is Palomar Holdings (PLMR) Attractive After Recent Share Price Pullback?

Wondering whether Palomar Holdings at around US$111.73 is priced for opportunity or risk? This article breaks the stock down so you can judge the value for yourself. The share price has seen a 12.1% pullback over the last 7 days and is down 15.2% year to date, after a 28.5% decline over the past year and a 128.2% gain across the last 3 years. Recent headlines around Palomar have focused on its position within the insurance sector and how investors are reassessing risk for specialty insurers...
NYSE:JLL
NYSE:JLLReal Estate

A Look At Jones Lang LaSalle (JLL) Valuation After Strong First Quarter Sales And Net Income Growth

Jones Lang LaSalle (JLL) opened its latest update with a first quarter earnings release showing higher sales and net income than a year earlier, a combination that helped frame the stock’s recent move. See our latest analysis for Jones Lang LaSalle. The strong first quarter update and the recent completion of a sizeable buyback program, which retired 15.66% of shares over several years, come as the stock trades at US$318.13. Despite a 6.86% 7 day share price decline and a 5.27% year to date...
NasdaqGM:STIM
NasdaqGM:STIMMedical Equipment

Neuronetics (STIM) Margin Compression Reinforces Bearish Clinic Mix Narrative

Neuronetics (STIM) has just put fresh numbers on the table for Q1 2026, and recent filings show quarterly revenue at US$41.8 million in Q4 2025 with a basic EPS loss of US$0.10, alongside trailing twelve month revenue of US$149.2 million and a basic EPS loss of US$0.59. Over recent quarters, the company has seen revenue move from US$18.5 million in Q3 2024 to US$22.5 million in Q4 2024 and then to US$42.8 million in Q4 2025, while quarterly basic EPS losses shifted from US$0.44 to US$0.35 and...
NYSE:BAX
NYSE:BAXMedical Equipment

Assessing Baxter International’s Valuation After Earnings Beat And Guidance Reaffirmation

Why Baxter International (BAX) is back on investors’ radar Baxter International (BAX) moved back into focus after first quarter results topped revenue and non GAAP profit expectations, management reiterated full year earnings guidance, and analysts responded with more constructive commentary on the stock. See our latest analysis for Baxter International. The better than expected first quarter and reaffirmed full year earnings guidance came after a tough stretch for shareholders, with a 90 day...
NYSE:GPK
NYSE:GPKPackaging

Graphic Packaging Holding (GPK) Margin Compression Tests Bullish Earnings Growth Narrative

Graphic Packaging Holding (GPK) opened 2026 on the back of a steady 2025, with Q4 revenue of US$2.1b, basic EPS of US$0.24 and net income of US$71m, framing expectations for the latest Q1 print. Over recent quarters, the company has seen quarterly revenue move in a narrow band between US$2.1b and US$2.2b, while basic EPS ranged from US$0.24 to US$0.55. This sets up a picture where investors are focusing less on sheer top line scale and more on how much of that flows through to profit. With...
NYSE:DOV
NYSE:DOVMachinery

Dover’s 2026 EPS Guidance and Revenue Outlook Could Be A Game Changer For Dover (DOV)

Dover Corporation recently reported past first-quarter 2026 results, with sales rising to US$2,053.62 million and net income at US$238.43 million, alongside modest increases in both basic and diluted earnings per share. The company also issued full-year 2026 guidance, projecting GAAP EPS between US$8.92 and US$9.12 on expected revenue growth of 5% to 7%, offering fresh insight into its earnings trajectory. We’ll now examine how Dover’s updated 2026 EPS guidance and revenue growth outlook...
NasdaqGS:SNEX
NasdaqGS:SNEXCapital Markets

What StoneX Group (SNEX)'s Q1 2026 Earnings and Insider Equity Moves Mean For Shareholders

StoneX Group Inc. is set to report its Q1 2026 earnings after market close, following a prior quarter that surpassed analysts’ EPS estimates and amid upbeat growth-focused research coverage. At the same time, the company’s board activity shows a mix of insider share sales, new restricted stock grants, and a Form 144 filing, offering a detailed view of how directors are managing and being compensated with equity. With Q1 results due and analysts highlighting earnings growth potential, we’ll...
NasdaqGS:KNSA
NasdaqGS:KNSABiotechs

Why Kiniksa Pharmaceuticals (KNSA) Is Up 5.4% After Raising 2026 Revenue Guidance And What's Next

In late April 2026, Kiniksa Pharmaceuticals International, plc reported past first-quarter 2026 results, with revenue of US$214.27 million and net income of US$22.59 million, alongside higher basic and diluted earnings per share from continuing operations versus a year earlier. On the same day, the company raised its 2026 net product revenue outlook to a range of US$930 million to US$945 million, signaling greater confidence in its ARCALYST franchise and overall portfolio execution. Now,...
NYSE:ADM
NYSE:ADMFood

ADM Margins Compress To 1.3% Challenging Bullish Narratives On Premium P/E

How Archer-Daniels-Midland’s Latest Numbers Set the Stage Archer-Daniels-Midland (ADM) opened Q1 2026 earnings season coming off Q4 2025 revenue of about US$18.6b and basic EPS of US$0.94, with trailing 12 month EPS at US$2.23 on revenue of roughly US$80.3b. Over the last year, the company has seen quarterly revenue move between US$18.6b and US$21.2b while basic EPS ranged from US$0.04 in Q3 2024 to US$0.94 in Q4 2025, setting a broad context for how current results land against recent...
NYSE:INVX
NYSE:INVXEnergy Services

Innovex International Q1 2026 Margin Compression Challenges Bullish Narratives On Earnings Quality

Q1 2026 earnings set against a shifting profit profile Innovex International (INVX) has followed up its recent results with trailing twelve month revenue of US$978.3 million and basic EPS of US$1.21, against quarterly figures that most recently showed Q4 2025 revenue of US$273.6 million and basic EPS of US$0.20. Over the past six reported quarters, revenue has ranged from US$151.8 million to US$273.6 million, while quarterly basic EPS has moved between US$0.20 and US$2.03. This gives...
NYSE:CAVA
NYSE:CAVAHospitality

CAVA Glazed Salmon And Drive Thru Push Test High P/E Expectations

CAVA Group (NYSE:CAVA) is rolling out a new Glazed Salmon menu item across its U.S. restaurants. The company is also pushing into more suburban locations that include drive thru formats. These moves mark a meaningful shift in how CAVA approaches both its menu and store footprint. CAVA Group comes into these changes with its stock at $90.34 and a year to date return of 49.2%, after a 13.4% gain over the past month. The 1 year return of a 3.2% decline shows the ride has not been smooth, which...
NasdaqGS:CIFR
NasdaqGS:CIFRSoftware

Cipher Digital (CIFR) EPS Loss Deepens Challenging Bullish Margin Improvement Narrative

Q1 2026 earnings snapshot Cipher Digital (CIFR) has reported Q1 2026 revenue of US$59.7 million and a basic EPS loss of US$1.85, alongside trailing twelve month revenue of US$223.9 million and a basic EPS loss of US$2.15. The company’s revenue moved from US$42.2 million in Q4 2024 to US$59.7 million in Q4 2025, while quarterly basic EPS shifted from a profit of US$0.05 to a loss of US$1.85 over the same period. This set of results keeps the focus on whether Cipher Digital can translate its...
NasdaqGS:CACC
NasdaqGS:CACCConsumer Finance

Assessing Credit Acceptance (CACC) Valuation After Recent Share Price Momentum

Recent performance snapshot and why Credit Acceptance is on radar Credit Acceptance (CACC) has drawn investor attention after a recent share move, with the stock up about 3.7% over the past day and roughly 26% over the past month. See our latest analysis for Credit Acceptance. The recent 30 day share price return of 26.21% stands out against a 15.81% year to date gain and a 5.77% one year total shareholder return. This suggests short term momentum has picked up compared with longer term...
NasdaqGS:SLAB
NasdaqGS:SLABSemiconductor

Assessing Silicon Labs (SLAB) Valuation After Strong Multi Period Share Price Gains

Silicon Laboratories stock: recent performance snapshot Silicon Laboratories (SLAB) continues to sit in focus after a strong year to date share price move, with the stock last closing at US$218.27 and showing positive returns over the past month and past 3 months. See our latest analysis for Silicon Laboratories. The recent share price momentum, including the 4.37% 1 month share price return and 65.44% year to date share price return, sits alongside a 104.55% 1 year total shareholder return...
NasdaqGS:EBAY
NasdaqGS:EBAYMultiline Retail

Evaluating eBay (EBAY) After Recent Share Price Momentum And Conflicting Valuation Signals

eBay stock moves after recent performance catches investor attention eBay (EBAY) is drawing fresh attention after a period in which the stock shows varied returns over different time frames, including the past month and past 3 months, prompting investors to reassess the marketplace business. See our latest analysis for eBay. While the share price pulled back 3.72% over the last trading day to US$105.26, the 30 day share price return of 7.73% and 90 day return of 21.66% sit alongside a 1 year...
NYSE:GOLD
NYSE:GOLDRetail Distributors

Is It Too Late To Consider Barrick Gold (GOLD) After Its Strong 1 Year Run?

Investors may be wondering if Gold.com at US$42.93 still offers value after its strong run, or if most of the easy gains are already behind it. The stock has moved around recently, with a 6.1% decline over the last 7 days, a 4.0% return over 30 days, and longer term returns of 23.5% year to date and 81.4% over 1 year. These moves have kept Gold.com in focus for investors watching how the Retail Distributors sector is being priced. Broader market attention on this kind of stock can influence...
NYSE:BLCO
NYSE:BLCOMedical Equipment

Will Stronger 2026 Guidance And ARVO Data Shift Bausch + Lomb's (BLCO) Innovation-Led Growth Narrative?

In late April 2026, Bausch + Lomb raised its 2026 revenue guidance to US$5.42–US$5.52 billion and showcased more than 40 scientific data presentations across its eye health portfolio and pipeline at the ARVO 2026 meeting, while also advancing B‑vitamin–based AMD research and launching PreserVision AREDS3 in the U.S. Together, the upgraded outlook and breadth of clinical and pipeline data underscored how Bausch + Lomb is tying science-led innovation directly to its commercial growth ambitions...
NYSE:IIPR
NYSE:IIPRIndustrial REITs

IIPR Q1 2026 FFO Softness Challenges Bullish Recovery Narrative

Innovative Industrial Properties (IIPR) opened 2026 with Q1 funds from operations of US$48.3 million, equal to FFO per share of US$1.73. This gives REIT focused investors a clean read on core earnings quality from the latest quarter. Over the past year, the business has reported total revenue ranging from US$62.9 million to US$76.7 million per quarter, with basic EPS between US$0.87 and US$1.38. Trailing 12 month net profit margins now sit at 41.9% compared with 51.1% a year earlier, pointing...
NasdaqGS:FELE
NasdaqGS:FELEMachinery

How Investors Are Reacting To Franklin Electric (FELE) Q1 Beat, Reaffirmed Outlook And Higher Dividend

Franklin Electric Co., Inc. has already reported first-quarter 2026 results, with sales of US$500.44 million and net income of US$34.33 million, while reaffirming full-year 2026 net sales guidance of US$2.17 billion to US$2.24 billion and declaring a quarterly dividend of US$0.28 per share. The combination of higher quarterly earnings per share and maintained full-year sales guidance underscores management’s confidence in the business while continuing to return cash to shareholders through...
NasdaqGS:OKTA
NasdaqGS:OKTAIT

Okta Targets AI Agent Security Gaps As Identity Governance Expands

Okta, Inc. (NasdaqGS:OKTA) has released new research on AI security, highlighting significant gaps in how enterprises govern AI agents. The company has introduced a product called Okta for AI Agents, designed to manage AI agents as identities within existing security frameworks. Okta’s findings indicate that most enterprises use AI agents, while about 90% do not yet have adequate policies and controls for these non-human identities. For investors tracking cybersecurity and identity...
NasdaqGS:EVGO
NasdaqGS:EVGOSpecialty Retail

EVgo (EVGO) EPS Loss Narrows To US$0.04 And Tests Bearish Profitability Narratives

EVgo (EVGO) has just opened its Q1 2026 earnings season story with trailing 12 month revenue of about US$384.1 million and a basic EPS loss of US$0.31, setting a clear top line scale against an ongoing bottom line loss. Over recent quarters the company has seen quarterly revenue move from US$67.5 million in Q3 2024 to US$118.5 million in Q4 2025, while quarterly basic EPS has ranged from a loss of US$0.11 to a loss of US$0.04 over the same period. This frames a business that is adding revenue...
NasdaqGS:HSTM
NasdaqGS:HSTMHealthcare Services

HealthStream (HSTM) Margin Compression To 6% Tests Bullish Long Term Growth Narratives

HealthStream (HSTM) sets the stage with steady top line and mixed earnings signals HealthStream (HSTM) has kicked off its Q1 2026 earnings season with a recent track record that shows quarterly revenue ranging from about US$73.5 million to US$79.7 million over 2025, alongside basic EPS between roughly US$0.09 and US$0.21. Over the same period, the company has seen revenue move from US$73.1 million in Q3 2024 to US$79.7 million in Q4 2025. Trailing twelve month EPS has sat between about...
NasdaqGM:EVER
NasdaqGM:EVERInteractive Media and Services

EverQuote (EVER) Net Margin Jump To 14.3% Tests Bullish Profitability Narrative

Q1 2026 results set the tone EverQuote (EVER) has just put fresh numbers on the table, with recent quarterly revenue of about US$195 million and basic EPS of US$1.60 setting the headline for its latest update after a year in which trailing twelve month EPS reached US$2.75 on revenue of roughly US$692.5 million. Over the last few reported quarters, the company has seen revenue move from US$147.5 million in Q4 2024 to US$195.3 million in Q4 2025. Quarterly basic EPS stepped from US$0.35 to...
NasdaqGS:PSKY
NasdaqGS:PSKYMedia

Paramount Skydance (PSKY) Margin Strain Deepens And Tests Bullish Profitability Narratives

Paramount Skydance (PSKY) has opened Q1 2026 earnings season with recent quarterly revenue in the range of about US$6.7b to US$8.1b and EPS swinging between a profit of US$0.23 and a loss of US$0.52 over the last four reported quarters, setting a cautious backdrop for investors focused on profitability. Over that period, the company has seen revenue move from US$7.2b in Q1 2025 to US$8.1b in Q4 2025, while basic EPS shifted from US$0.23 in Q1 2025 to a loss of US$0.52 in Q4 2025, reflecting...